Your browser doesn't support javascript.
loading
Influenza vaccination can induce new-onset anticardiolipins but not ß2-glycoprotein-I antibodies among patients with systemic lupus erythematosus.
Vista, E S; Crowe, S R; Thompson, L F; Air, G M; Robertson, J M; Guthridge, J M; James, J A.
Afiliación
  • Vista ES; Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.
Lupus ; 21(2): 168-74, 2012 Feb.
Article en En | MEDLINE | ID: mdl-22235049
BACKGROUND: Antiphospholipid syndrome is characterized by autoantibodies against cardiolipins (aCL), lupus anticoagulant, and independent ß2-glycoprotein (ß2GPI). Controversy exists as to whether vaccination triggers the development of antiphospholipid antibodies (aPL) in patients with systemic lupus erythematosus (SLE). METHODS: Patients with SLE (101) and matched controls (101) were enrolled from 2005-2009 and received seasonal influenza vaccinations. Sera were tested by ELISA for aCL at baseline, 2, 6, and 12 weeks after vaccination. Vaccine responses were ranked according to an overall anti-influenza antibody response index. Individuals with positive aCL were further tested for ß2GPI antibodies. RESULTS: Patients with SLE and healthy controls can develop new-onset aCL post vaccination, although at rates which do not differ between patients and controls (12/101 cases and 7/101 controls, OR 1.81, p = 0.34). New-onset moderate aCL are slightly enriched in African American SLE patients (5/36 cases; p = 0.094). The optical density measurements for aCL reactivity in patients were significantly higher than baseline at 2 weeks (p < 0.05), 6 weeks (p < 0.05), and 12 weeks (p < 0.05) post vaccination. No new ß2GPI antibodies were detected among patients with new aCL reactivity. Vaccine response was not different between patients with and without new-onset aCL reactivity (p = 0.43). CONCLUSIONS: This study shows transient increases in aCL, but not anti-ß2GPI responses, after influenza vaccination.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Autoanticuerpos / Vacunas contra la Influenza / Vacunación / Anticuerpos Anticardiolipina / Beta 2 Glicoproteína I / Lupus Eritematoso Sistémico Límite: Female / Humans Idioma: En Revista: Lupus Asunto de la revista: REUMATOLOGIA Año: 2012 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Autoanticuerpos / Vacunas contra la Influenza / Vacunación / Anticuerpos Anticardiolipina / Beta 2 Glicoproteína I / Lupus Eritematoso Sistémico Límite: Female / Humans Idioma: En Revista: Lupus Asunto de la revista: REUMATOLOGIA Año: 2012 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido